Quick answers
- What is Afinitor Disperz?
- Afinitor Disperz is a brand name of Everolimus, a prescription medicine. The FDA NDC Directory lists 3 Afinitor Disperz products in 3 strengths and forms.
- Who makes Afinitor Disperz?
- Novartis Pharm holds the FDA application for Afinitor Disperz (NDA203985, approved August 29, 2012).
- Is there a generic or store brand of Afinitor Disperz?
- Yes. The FDA NDC Directory lists 12 other products with the same active ingredients, strength and form as a Afinitor Disperz product, 12 of them generic. Ask your pharmacist whether one is right for you.
- Has Afinitor Disperz been recalled?
- No recall linked to Afinitor Disperz products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Afinitor Disperz is
Each Afinitor Disperz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Everolimus · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| everolimus 2 mg tablet, for suspension (oral) | Afinitor Disperz | 4 products, 4 companies | DailyMed |
| everolimus 3 mg tablet, for suspension (oral) | Afinitor Disperz | 4 products, 4 companies | DailyMed |
| everolimus 5 mg tablet, for suspension (oral) | Afinitor Disperz | 4 products, 4 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Everolimus →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA203985 | Novartis Pharm | August 29, 2012 | 3 |
Companies that list Afinitor Disperz
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Afinitor Disperz products.
- Novartis Pharmaceuticals Corporation3 products
Recalls
No recall linked to Afinitor Disperz products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.